transplant drug

Novartis’s Patent on Transplant Drug Zortress Invalidated

A US federal judge recently invalidated a Novartis AG patent on its transplantation medicine drug Zortress.  Zortress is a prescription medicine (approved in 2010 and contains the generic ingredient everolimus) used to prevent transplant rejection in people who have received… Continue Reading →

© 2020 Dawn Ellmore Employment Blog — Powered by WordPress

Theme by Anders NorenUp ↑